Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | NCEH1 | Q6PIU2 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL208499 | 0.84 | — | — | |
| Ammonia Solution, Strong SCHEMBL9456636 | 0.81 | — | — | |
| SCHEMBL1310229 | 0.81 | — | — | |
| SCHEMBL28003019 | 0.72 | ALOX15 (0.38) | KDM4ETSHRALOX15ALDH1A1 | |
| Methyl Carbamate SCHEMBL28075490 | 0.70 | ALDH1A1 (0.35) | KDM4EGAANPSR1TSHRALOX15 | |
| Trifluoroacetic Acid SCHEMBL29678801 | 0.68 | RAB9A (0.33) | RAB9ACHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL19483214 | 0.67 | HCAR2 (0.35) | KDM4EGAAALDH1A1 | |
| Anthraquinone SCHEMBL29674372 | 0.67 | KEAP1 (0.50) | RAB9AKDM4EALOX15ALDH1A1NPC1 | |
| SCHEMBL2895036 | 0.67 | — | — | |
| SCHEMBL3360045 | 0.66 | ALDH1A1 (0.41) | RAB9ACHRM2CHRM4CHRM5CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1737834-B1 | METHOD FOR PRODUCING 1,3,5-TRIAZINE CARBAMATES AND UREAS | BASF AG (DE) | 2007-10-03 | — | — | EP | disclosed |
| EP-0930303-B1 | A process for preparing isocyanate compounds from haloaminotriazines and acid halides | CYTEC TECH CORP (US) | 2004-02-04 | — | — | EP | disclosed |
| EP-0933371-B1 | N-halo acid amides | CYTEC TECH CORP (US) | 2003-04-09 | — | — | EP | disclosed |
| EP-0565774-B1 | Process for preparing amide derivatives from halominotriazines and acid halides | CYTEC TECH CORP (US) | 2001-03-28 | — | — | EP | disclosed |
| EP-0933369-A1 | Tris-(omega-haloacyl)melamines | CYTEC TECHNOLOGY CORP. (US) | 1999-08-04 | — | — | EP | disclosed |
| EP-0933371-A1 | N-halo acid amides | CYTEC TECHNOLOGY CORP. (US) | 1999-08-04 | — | — | EP | disclosed |
| EP-0933370-A1 | Tris-(2,2,6,6-tetramethyl-piperid-4-yl-aminocarbonyl)melamine | CYTEC TECHNOLOGY CORP. (US) | 1999-08-04 | — | — | EP | disclosed |
| EP-0930303-A2 | A process for preparing isocyanate compounds from haloaminotriazines and acid halides | CYTEC TECHNOLOGY CORP. (US) | 1999-07-21 | — | — | EP | disclosed |
| US-5571915-A | Process for preparing amide derivatives from haloaminotriazines and acid halides | CYTEC TECHNOLOGY CORP. (US) | 1996-11-05 | — | — | US | disclosed |
| US-5405959-A | Haloaminotraizines and acid halides | CYTEC TECHNOLOGY CORP. (US) | 1995-04-11 | — | — | US | disclosed |
| US-5288865-A | Process for preparing amide derivatives from haloaminotriazines and acid halides | AMERICAN CYANAMID COMPANY (US) | 1994-02-22 | — | — | US | disclosed |
| EP-0565774-A2 | Process for preparing amide derivatives from halominotriazines and acid halides | CYTEC TECHNOLOGY CORP. (US) | 1993-10-20 | — | — | EP | disclosed |
| EP-0541966-A2 | Process for preparing amide derivatives from halomines and acid halides | AMERICAN CYANAMID COMPANY (US) | 1993-05-19 | — | — | EP | disclosed |